Guggenheim Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $38.4M | Buy |
1,367,689
+159,332
| +13% | +$4.24M | 0.3% | 67 |
|
|
2025
Q4 | $30.1M | Buy |
1,208,357
+41,805
| +4% | +$1.05M | 0.22% | 96 |
|
|
2025
Q3 | $29.7M | Buy |
1,166,552
+19,388
| +2% | +$479K | 0.22% | 92 |
|
|
2025
Q2 | $27.8M | Sell |
1,147,164
-25,763
| -2% | -$601K | 0.22% | 94 |
|
|
2025
Q1 | $29.7M | Sell |
1,172,927
-74,096
| -6% | -$1.94M | 0.27% | 81 |
|
|
2024
Q4 | $33.1M | Sell |
1,247,023
-75,970
| -6% | -$2.06M | 0.27% | 78 |
|
|
2024
Q3 | $38.3M | Sell |
1,322,993
-107,587
| -8% | -$3.14M | 0.27% | 70 |
|
|
2024
Q2 | $40M | Sell |
1,430,580
-41,646
| -3% | -$1.15M | 0.28% | 68 |
|
|
2024
Q1 | $40.9M | Buy |
1,472,226
+52,909
| +4% | +$1.47M | 0.29% | 65 |
|
|
2023
Q4 | $40.9M | Buy |
1,419,317
+54,297
| +4% | +$1.64M | 0.31% | 53 |
|
|
2023
Q3 | $45.3M | Buy |
1,365,020
+158,352
| +13% | +$5.6M | 0.39% | 41 |
|
|
2023
Q2 | $44.3M | Buy |
1,206,668
+70,367
| +6% | +$2.74M | 0.35% | 48 |
|
|
2023
Q1 | $46.4M | Sell |
1,136,301
-85
| -0% | -$3.67K | 0.39% | 43 |
|
|
2022
Q4 | $58.2M | Sell |
1,136,386
-46,526
| -4% | -$2.23M | 0.51% | 22 |
|
|
2022
Q3 | $51.8M | Sell |
1,182,912
-45,763
| -4% | -$2.22M | 0.47% | 24 |
|
|
2022
Q2 | $64.4M | Sell |
1,228,675
-157,294
| -11% | -$8.02M | 0.51% | 21 |
|
|
2022
Q1 | $71.8M | Sell |
1,385,969
-159,853
| -10% | -$8.29M | 0.43% | 32 |
|
|
2021
Q4 | $91.3M | Buy |
1,545,822
+29,250
| +2% | +$1.45M | 0.48% | 27 |
|
|
2021
Q3 | $65.2M | Buy |
1,516,572
+72,600
| +5% | +$3.22M | 0.39% | 31 |
|
|
2021
Q2 | $56.5M | Sell |
1,443,972
-17,536
| -1% | -$682K | 0.33% | 44 |
|
|
2021
Q1 | $53M | Buy |
1,461,508
+40,497
| +3% | +$1.44M | 0.35% | 41 |
|
|
2020
Q4 | $52.3M | Buy |
1,421,011
+1,929
| +0.1% | +$70.8K | 0.33% | 40 |
|
|
2020
Q3 | $49.4M | Sell |
1,419,082
-51,732
| -4% | -$1.81M | 0.36% | 39 |
|
|
2020
Q2 | $45.6M | Buy |
1,470,814
+82,702
| +6% | +$2.81M | 0.35% | 41 |
|
|
2020
Q1 | $43M | Sell |
1,388,112
-86,702
| -6% | -$2.95M | 0.43% | 28 |
|
|
2019
Q4 | $54.8M | Sell |
1,474,814
-80,168
| -5% | -$2.86M | 0.41% | 32 |
|
|
2019
Q3 | $53M | Buy |
1,554,982
+11,594
| +0.8% | +$422K | 0.42% | 27 |
|
|
2019
Q2 | $63.4M | Sell |
1,543,388
-7,676
| -0.5% | -$305K | 0.52% | 17 |
|
|
2019
Q1 | $62.5M | Buy |
1,551,064
+71,947
| +5% | +$2.88M | 0.51% | 16 |
|
|
2018
Q4 | $61.3M | Sell |
1,479,117
-265,066
| -15% | -$11M | 0.52% | 16 |
|
|
2018
Q3 | $72.9M | Buy |
1,744,183
+93,536
| +6% | +$3.6M | 0.48% | 15 |
|
|
2018
Q2 | $56.8M | Sell |
1,650,647
-1,710,999
| -51% | -$58.5M | 0.38% | 24 |
|
|
2018
Q1 | $113M | Sell |
3,361,646
-78,960
| -2% | -$2.71M | 0.28% | 33 |
|
|
2017
Q4 | $118M | Buy |
3,440,606
+159,903
| +5% | +$5.45M | 0.28% | 30 |
|
|
2017
Q3 | $111M | Sell |
3,280,703
-129,945
| -4% | -$4.18M | 0.26% | 28 |
|
|
2017
Q2 | $109M | Buy |
3,410,648
+420,584
| +14% | +$13.3M | 0.29% | 25 |
|
|
2017
Q1 | $97M | Sell |
2,990,064
-167,287
| -5% | -$5.27M | 0.26% | 35 |
|
|
2016
Q4 | $97.3M | Buy |
3,157,351
+457,206
| +17% | +$14M | 0.28% | 31 |
|
|
2016
Q3 | $86.8M | Sell |
2,700,145
-200,568
| -7% | -$6.71M | 0.27% | 34 |
|
|
2016
Q2 | $96.9M | Sell |
2,900,713
-195,265
| -6% | -$6.23M | 0.3% | 27 |
|
|
2016
Q1 | $87.1M | Sell |
3,095,978
-206,071
| -6% | -$5.89M | 0.27% | 32 |
|
|
2015
Q4 | $101M | Buy |
3,302,049
+20,087
| +0.6% | +$632K | 0.29% | 25 |
|
|
2015
Q3 | $97.8M | Sell |
3,281,962
-561,875
| -15% | -$18M | 0.3% | 19 |
|
|
2015
Q2 | $122M | Buy |
3,843,837
+198,126
| +5% | +$6.46M | 0.3% | 18 |
|
|
2015
Q1 | $120M | Sell |
3,645,711
-230,732
| -6% | -$7.34M | 0.28% | 20 |
|
|
2014
Q4 | $115M | Buy |
3,876,443
+369,577
| +11% | +$10.6M | 0.29% | 24 |
|
|
2014
Q3 | $98.4M | Buy |
3,506,866
+16,839
| +0.5% | +$473K | 0.24% | 33 |
|
|
2014
Q2 | $98.3M | Buy |
3,490,027
+424,767
| +14% | +$12.1M | 0.25% | 32 |
|
|
2014
Q1 | $93.4M | Buy |
3,065,260
+367,860
| +14% | +$11M | 0.27% | 29 |
|
|
2013
Q4 | $78.4M | Buy |
2,697,400
+204,104
| +8% | +$5.94M | 0.24% | 43 |
|
|
2013
Q3 | $67.9M | Sell |
2,493,296
-75,871
| -3% | -$2.06M | 0.24% | 40 |
|
|
2013
Q2 | $68.3M | Buy |
+2,569,167
| New | +$71M | 0.29% | 28 |
|
Other funds holding PFE
VCM
VPM
Guggenheim Capital's PFE Position: Q1 2026 in Review
Guggenheim Capital increased its Pfizer (PFE) stake by 13% in Q1 2026, buying an estimated $4.24M and bringing the position to 1,367,689 shares worth $38.4M. The position accounts for 0.3% of the portfolio, ranked #67.
Guggenheim Capital first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $122M in Q2 2015. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Guggenheim Capital held 1,367,689 shares of Pfizer worth $38.4M as of Q1 2026.
- Guggenheim Capital bought 159,332 Pfizer shares in Q1 2026, an estimated $4.24M.
- Pfizer made up 0.3% of Guggenheim Capital's portfolio in Q1 2026, its #67 holding.
- Guggenheim Capital first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Guggenheim Capital's Pfizer position peaked at $122M in Q2 2015.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.